Results of a long-term, federally funded study of cognitively healthy adults — most with a family history of Alzheimer’s disease — have added to evidence that low spinal fluid levels of a protein linked to learning and memory in mice may serve as an early predictor of mild cognitive impairment (MCI) years before symptoms appear.
FDA approves Johnson & Johnson’s multiple myeloma treatment
In a Phase III trial, the D-VRd regimen lowered disease progression or death risk by 60% in newly diagnosed multiple myeloma. Credit: Nemes Laszlo /
July 31, 2024